DOI:
10.1055/s-00000089
Ultraschall in der Medizin
LinksClose Window
References
Orloff DG.
Use of surrogate endpoints: a practical necessity in lipid-altering and antiatherosclerosis drug development.
Am J Cardiol 2001; 87(4A): 35A-41A
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.